For the first time, scientists have used CRISPR to edit DNA while it's still inside a person's body, NPR has learned.https://t.co/xu6GsKGqpl
— NPR (@NPR) March 4, 2020
According to the researchers, metformin works on the ‘longevity gene’ SIRT1 to protect the user’s vascular system against deterioration caused by glucose toxicity.
No comments:
Post a Comment